Diagnostics Pipeline: Cizzle Bio Introduces Test for Earlier Lung Cancer Detection
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
The CIZ1B biomarker blood-based assay has 95% sensitivity for detecting earliest stage of the cancer
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
The skin-based test can be used on children as young as two days old
AMP Annual Meeting attendees showed strong interest in the blood test
SimplyTest’s saliva-based HPV tests will be marketed to dentists and functional medicine practices
The assay detects the presence of three different proteins and is slightly more accurate than a test Quest released earlier this year